PM HOLDINGS, LLC v. HEART OF TEXAS SURGERY CENTER, PLLC

District Court, W.D. Texas·Decided April 26, 2022·No. 6:21-cv-00644·Unknown

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE WESTERN DISTRICT OF TEXAS WACO DIVISION

PM HOLDINGS, LLC, an Arizona Limited Liability Company,

Plaintiff,

v. Civil Action No.: 6:21-cv-00644-ADA HEART OF TEXAS SURGERY CENTER, PLLC, a Texas Professional Limited Liability Company; and HEART OF TEXAS CATH LAB, PLLC, a Texas Professional Limited Liability Company,

Defendants.

CLAIM CONSTRUCTION MEMORANDUM OPINION AND ORDER Before the Court are the Parties’ claim construction briefs: Defendants Heart of Texas Surgery Center, PLLC and Heart of Texas Cath Lab, PLLC’s (“Defendants” or “HOT”) Opening and Reply briefs (ECF No. 24 and 26, respectively), Plaintiff PM Holdings, LLC’s (“Plaintiff” or “PM Holdings”) Response and Sur-reply briefs (ECF No. 25 and 27, respectively), and the Parties’ Joint Claim Construction Statement (ECF No. 28). This matter was referred to the undersigned on April 1, 2022 (ECF No. 29) for disposition. The Court considered the Parties’ briefs and provided preliminary constructions in advance of the Markman hearing. A Markman hearing was held on April 8, 2022. After further considering the arguments at the Markman hearing, the Court notified the parties at the hearing that it would adopt its preliminary constructions as its final constructions. This Order does not alter any of those constructions and enters those final constructions now. I. BACKGROUND Plaintiff alleges that Defendant infringes thirteen claims from U.S. Patent No. 9,322,188 (“the ’188 patent”) and U.S. Patent No. 9,334,664 (“the ’664 patent”) (collectively, the “Asserted Patents”). The Asserted Patents share an identical title (“Hybrid Operating Room for Combined Surgical Services in an Ambulatory Surgical Center”) and similar, albeit non-identical,

specifications. The Asserted Patents generally claim a facility containing at least a hybrid operating room, an imaging device, an operating table, a power room, an air change system, a conduit, and a door. In claim 16 of the ’188 Patent, the facility is a stationary ambulatory surgical center within a building. In claim 22 of the ’664 Patent, the claimed facility is the building.

Figure 1 of the Asserted Patents (reproduced below) “illustrates a cross-section of an ambulatory surgical center according to certain embodiments of the present invention.” ’664 Patent at 4:9-10; ’188 Patent at 4:8-10. The “ambulatory surgical center” is labelled 100 in Figure 1, the “hybrid operating room” is labelled 105, and the power room is labelled 135. In Figure 1, “[t]he ambulatory surgical center 100 can further include a power room 135 adjacent to the operating room.” ’188 Patent at 4:59-60; ’664 Patent at 5:6-7. 100 160 120 105 JL 125a 410 135 155 110 140 145

:

130 1255 1ash “115

Figure 1 of the Asserted Patents Figure 2 of the Asserted Patents describes a method of manufacturing an ambulatory surgical center, and in this embodiment, the power room is described as being “‘adjacent” the operating room. (‘188 Patent, Figure 2; '664 Patent, Figure 2.): 206 Operating Boom fOr} Ho [ms | sewae | | | Install Conduttis) | Shield Wills | | Bélweer Power | | | Roomand OR | ae | de | | snsatiemaearcy | Device | | Power Source | | Ina ont | || acct | | | Component to Floor } << | ————$<$— Buld Adjacent | | Monitor | Power Room | | Compenentic | —————— | L__Ceitrg Ho | e258 install Power Sognihy | | install Air Charge | for imoging Device | | System | | |

Figure 2 of the Asserted Patents

Il. LEGAL STANDARDS A. Claim Construction Generally

The general rule is that claim terms are given their plain-and-ordinary meaning. Phillips v. AWH Corp., 415 F.3d 1303, 1312 (Fed. Cir. 2005) (en banc); Azure Networks, LLC v. CSR PLC, 771 F.3d 1336, 1347 (Fed. Cir. 2014), vacated on other grounds, 575 U.S. 959, 959 (2015) (“There is a heavy presumption that claim terms carry their accustomed meaning in the relevant community at the relevant time.”). The plain and ordinary meaning of a term is the “meaning

that the term would have to a person of ordinary skill in the art in question at the time of the invention.” Philips, 415 F.3d at 1313. The “only two exceptions to [the] general rule” that claim terms are construed according to their plain and ordinary meaning are when the patentee (1) acts as his/her own lexicographer or (2) disavows the full scope of the claim term either in the specification or during prosecution. Thorner v. Sony Computer Entm’t Am. LLC, 669 F.3d 1362, 1365 (Fed. Cir. 2012). To act as his/her own lexicographer, the patentee must “clearly set forth a definition of the disputed claim term,” and “clearly express an intent to define the term.” Id. Intrinsic evidence is the primary resource for claim construction. See Power-One, Inc. v.

Artesyn Techs., Inc., 599 F.3d 1343, 1348 (Fed. Cir. 2010) (citing Phillips, 415 F.3d at 1312). For certain claim terms, “the ordinary meaning of claim language as understood by a person of skill in the art may be readily apparent even to lay judges, and claim construction in such cases involves little more than the application of the widely accepted meaning of commonly understood words.” Phillips, 415 F.3d at 1314; see also Medrad, Inc. v. MRI Devices Corp., 401 F.3d 1313, 1319 (Fed. Cir. 2005) (“We cannot look at the ordinary meaning of the term . . . in a vacuum. Rather, we must look at the ordinary meaning in the context of the written description and the prosecution history.”). But for claim terms with less-apparent meanings, courts consider “‘those sources available to the public that show what a person of skill in the art would have understood disputed claim language to mean[,] [including] the words of the claims themselves, the remainder of the specification, the prosecution history, and extrinsic evidence concerning relevant scientific principles, the meaning of technical terms, and the state of the art.’” Phillips, 415 F.3d at 1314 (quoting Innova, 381 F.3d at 1116). “Like the specification, the prosecution history provides evidence of how the PTO and

the inventor understood the patent.” Phillips, 415 F.3d at 1317. “Distinguishing the claimed invention over the prior art during prosecution indicates what a claim does not cover.” Spectrum Int’l, Inc. v. Sterilite Corp., 164 F.3d 1372, 1378–79 (Fed. Cir. 1988). The doctrine of prosecution disclaimer precludes a patentee from recapturing a specific meaning that was previously disclaimed during prosecution. Omega Eng’g, Inc. v. Raytek Corp., 334 F.3d 1314, 1323 (Fed. Cir. 2003). “[F]or prosecution disclaimer to attach, our precedent requires that the alleged disavowing actions or statements made during prosecution be both clear and unmistakable.” Id. at 1325–26. Accordingly, when “an applicant’s statements are amenable to multiple reasonable interpretations, they cannot be deemed clear and unmistakable.” 3M

Innovative Props. Co. v. Tredegar Corp., 725 F.3d 1315, 1326 (Fed. Cir. 2013). “Although the specification may aid the court in interpreting the meaning of disputed claim language, particular embodiments and examples appearing in the specification will not generally be read into the claims.” Constant v. Advanced Micro-Devices, Inc., 848 F.2d 1560, 1571 (Fed.

Free access — add to your briefcase to read the full text and ask questions with AI

PM HOLDINGS, LLC v. HEART OF TEXAS SURGERY CENTER, PLLC, (W.D. Tex. 2022).

PM HOLDINGS, LLC v. HEART OF TEXAS SURGERY CENTER, PLLC (PM HOLDINGS, LLC v. HEART OF TEXAS SURGERY CENTER, PLLC) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Enzo Biochem, Inc. v. Applera Corp.
599 F.3d 1325 (Federal Circuit, 2010)
Power-One, Inc. v. Artesyn Technologies, Inc.
599 F.3d 1343 (Federal Circuit, 2010)
American Medical Systems, Inc. v. Biolitec, Inc.
618 F.3d 1354 (Federal Circuit, 2010)
Medrad, Inc. v. Mri Devices Corp.
401 F.3d 1313 (Federal Circuit, 2005)
Thorner v. Sony Computer Entertainment America LLC
669 F.3d 1362 (Federal Circuit, 2012)
Stanton J. Rowe v. Michael Dror and Paul Trescony
112 F.3d 473 (Federal Circuit, 1997)
3m Innovative Properties v. Tredegar Corporation
725 F.3d 1315 (Federal Circuit, 2013)
Nautilus, Inc. v. Biosig Instruments, Inc.
134 S. Ct. 2120 (Supreme Court, 2014)
Azure Networks, LLC v. Csr, Plc
771 F.3d 1336 (Federal Circuit, 2014)
Advanced Aerospace Technologies, Inc. v. United States
124 Fed. Cl. 282 (Federal Claims, 2015)
Spectrum International, Inc. v. Sterilite Corp.
164 F.3d 1372 (Federal Circuit, 1998)
In re: Neurografix ('360) Patent Litigation
201 F. Supp. 3d 206 (D. Massachusetts, 2016)